Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
Cologuard is designed to detect DNA taken from a stool sample that indicates the presence of colorectal cancer or pre-cancerous polyps.
The results, determined during a DeeP-C clinical study, will be submitted to the FDA as part of the test’s pre-market approval process.
More Articles on Gastroenterology:
20 Statistics on Gastroenterologist Burnout
3 Statistics on Colonoscopy Procedure Times in ASCs
EndoSoft to Present GI Software at Digestive Disease Week in Orlando
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
